Regulus Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for RGLS

Based on 2 analysts offering 12 month price targets for Regulus Therapeutics Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell RGLS stock?

Based on 2 analysts offering ratings for Regulus Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
1 analysts 50%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RGLS stock forecasts and price targets.

RGLS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-09-21Find Out Why

1 of 1

RGLS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RGLS$1.49$10.50+604.70%Strong Buy

Regulus Therapeutics Stock Forecast FAQ

Is Regulus Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: RGLS) stock is to Strong Buy RGLS stock.

Out of 2 analysts, 1 (50%) are recommending RGLS as a Strong Buy, 1 (50%) are recommending RGLS as a Buy, 0 (0%) are recommending RGLS as a Hold, 0 (0%) are recommending RGLS as a Sell, and 0 (0%) are recommending RGLS as a Strong Sell.

If you're new to stock investing, here's how to buy Regulus Therapeutics stock.

What is RGLS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year RGLS price target, the average RGLS price target is $10.50, with the highest RGLS stock price forecast at $12.00 and the lowest RGLS stock price forecast at $9.00.

On average, Wall Street analysts predict that Regulus Therapeutics's share price could reach $10.50 by Sep 21, 2024. The average Regulus Therapeutics stock price prediction forecasts a potential upside of 604.7% from the current RGLS share price of $1.49.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.